No description
-
2017 (v1)PublicationUploaded on: April 14, 2023
-
2023 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2023 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2018 (v1)Publication
Objective: The co-occurrence of general medical conditions (GMCs) and major psychiatric disorders is well documented. The aim of this study was to assess the prevalence of GMCs in patients with a primary diagnosis of obsessive-compulsive disorder (OCD) and, secondly, to investigate which clinical variables are associated with the presence of a...
Uploaded on: March 27, 2023 -
2022 (v1)Publication
IntroductionLithium treatment is considered the gold standard for the long-term management of bipolar disorder and recurrent unipolar depression. It is also extremely effective in other psychiatric conditions characterized by impulsivity and aggression, and for the prevention of suicidal behaviours.Areas coveredThis paper provides a scoping...
Uploaded on: January 31, 2024 -
2023 (v1)Publication
BackgroundLithium is one of the most consistently effective treatment for mood disorders. However, patients may show a high level of heterogeneity in treatment response across the lifespan. In particular, the benefits of lithium use may vary in special clinical conditions. The aim of this study was to test this hypothesis by conducting an...
Uploaded on: January 31, 2024 -
2022 (v1)Publication
Introduction: Lurasidone is an atypical antipsychotic agent approved in the European Union for the treatment of schizophrenia in adults and adolescents (13-17 years). Clinical trials have shown a generally favorable balance between efficacy and tolerability. Areas covered: This paper provides a review and commentary regarding the use of...
Uploaded on: February 14, 2024